Meet Boston Heart Diagnostics | 2018 CMT/DPC Journal FORUM in Atlanta, OCT. 26-27, 2018 Sponsor
Boston Heart is transforming the treatment of cardiovascular disease with novel diagnostics, reports, and a personalized, scientifically designed nutrition and lifestyle program that have the power to change the way healthcare providers and patients communicate about heart health. Our company was founded by accomplished lipidologists, clinicians and scientists who have dedicated their careers to revealing the mechanisms of cardiovascular disease progression. Through extensive research and clinical studies, they showed that standard lipid profiling did not adequately identify individuals at risk for cardiovascular disease. They went on to develop and make available advanced methodologies to address this unmet medical need.
- Check out the latest addition to Boston Heart’s offering: The Diagnostic Report
Everything we do, from the tests we perform to our treatment considerations and our Lifestyle Program, uses an evidence-based approach, grounded in over thirty years of original scientific research.
Our Boston Heart HDL Map® and Boston Heart Cholesterol Balance® tests have been performed on over 380,000 and 280,000 patients respectively. Boston Heart’s exclusive test for Statin Induced Myopathy (SLCO1B1) Genotype has been performed on over 250,000 patients. Nearly 26,000 patients have had the Boston Heart Prediabetes Assessment® and the Boston Heart Fatty Acid Balance™ test has been performed on over 57,000 patients.
We have built a leadership team of experienced business professionals, clinicians and scientists who work in close partnership with healthcare providers to improve patient outcomes. We provide our services through our CAP-accredited, CLIA-certified clinical laboratory and staff of supporting medical experts.
Categories: National Headlines